US Broker Ratings

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating a 19.46% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $1.23..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating Growth Potential with a 12.93% Upside

Investors seeking opportunities in the healthcare sector may find 10x Genomics, Inc. (NASDAQ: TXG) to be a compelling case study. This life science technology company, headquartered in Pleasanton, California, is..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Navigating the Uncharted Waters of a $1.02 Billion Bioelectric Medicine Innovator

Pulse Biosciences, Inc. (NASDAQ: PLSE) operates at the cutting edge of healthcare innovation, focusing on bioelectric medicine. This sector, which combines medical devices with electrical stimulation, offers significant potential for..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Biotech Player with an 83% Potential Upside

Investors eyeing the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing opportunity. With a market cap of $1.71 billion, this San Diego-based biopharmaceutical company focuses on developing..

Harrow, Inc. (HROW) Stock Analysis: Eyeing an 86% Upside Potential in the Healthcare Sector

Harrow, Inc. (NASDAQ: HROW), a specialized player in the healthcare sector focusing on the development and commercialization of ophthalmic pharmaceutical products, presents an intriguing proposition for investors. With a market..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unraveling a Potential 264% Upside in Immunotherapy

Janux Therapeutics, Inc. (NASDAQ: JANX) is lighting up the biotechnology sector with its advanced immunotherapy developments. As a clinical stage biopharmaceutical company, Janux is harnessing the power of its proprietary..

Ascentage Pharma (AAPG): Investor Outlook Amid Significant Revenue Growth and Market Challenges

Ascentage Pharma Group International (AAPG) is capturing attention in the biotechnology sector with its compelling growth story and innovative therapeutic pipeline. Based in Suzhou, China, this clinical-stage biotechnology firm is..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook Highlights 35.55% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing opportunity for investors seeking growth in the healthcare sector. With a market capitalization of $1.19 billion, this Houston-based company is making..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Unveiling a Potential 44.95% Upside for Investors

BioLife Solutions, Inc. (NASDAQ: BLFS) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Bothell, Washington, BioLife Solutions has..

IDEAYA Biosciences (IDYA) Stock Analysis: Uncovering a 142.99% Potential Upside in Biotechnology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) presents a compelling opportunity for investors seeking growth in the dynamic biotechnology sector. Headquartered in South San Francisco, California, IDEAYA is a precision medicine oncology..

Evolent Health, Inc (EVH) Stock Analysis: Navigating a 33.9% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NASDAQ: EVH), a prominent player in the health information services industry, has positioned itself as a key innovator in the U.S. healthcare sector. The company specializes in..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 171% Potential Upside in Biotech

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company focused on developing monoclonal antibodies for autoimmune diseases, is attracting significant attention from investors. With a market capitalization of $2.73 billion, Immunovant..

agilon health, inc. (AGL) Stock Analysis: Unveiling an 84.94% Upside Potential in Healthcare

agilon health, inc. (NYSE: AGL), a prominent player in the healthcare sector, stands at a fascinating juncture with substantial upside potential of 84.94% according to analyst consensus. This potential is..

Celldex Therapeutics (CLDX) Stock Analysis: A High-Potential Play with 187.66% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is capturing attention in the biotechnology sector with a promising pipeline focused on severe inflammatory, allergic, and autoimmune diseases. As a biopharmaceutical company headquartered in..

Novavax, Inc. (NVAX) Investor Outlook: 113% Potential Upside Amidst Biotech Volatility

In the dynamic landscape of biotechnology, Novavax, Inc. (NASDAQ: NVAX) presents a compelling, albeit risky, opportunity for investors seeking exposure to the healthcare sector. With a market capitalization of $1.02..

SS Innovations International (SSII) Stock Analysis: Navigating the Robotics Revolution in Healthcare

In the rapidly evolving healthcare sector, SS Innovations International Inc. (SSII) stands out as a key player in the medical devices industry, driven by its innovative surgical robotics solutions. Based..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Impressive 50.8% Potential Upside Awaits Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is drawing attention in the investor community, especially those with an eye on the healthcare sector. The biopharmaceutical company, based in Westlake Village, California, focuses..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a Potential 26.84% Upside for Investors

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the realm of health information services. With a current market capitalization..

Merus N.V. (MRUS) Stock Analysis: Unpacking the 71.48% Potential Upside

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to developing antibody therapeutics. Based in Utrecht, the Netherlands,..

Protagonist Therapeutics, Inc. (PTGX) Investor Outlook: Analyzing a 24.84% Potential Upside in the Biotechnology Sector

Investors eyeing opportunities in the biotechnology sector should consider Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a company with a market capitalization of $3.43 billion. Operating within the healthcare sector, Protagonist specializes..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds